Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helicobacter

Showing results (421-430 of 2,296) with videos related to

Pageof 230
Sort By:
Helicobacter|June 1, 2022
Efficacy and safety of low-dose rifabutin-based 7-day triple therapy as a third- or later-line Helicobacter pylori eradication regimenKazumi Inokuchi, Hideki Mori, Juntaro Matsuzaki, et al.
Helicobacter|December 20, 2022
Helicobacter pylori-positive chronic atrophic gastritis and cellular senescenceShi-Yu Zheng, Lu Zhu, Lu-Yi Wu, et al.
Helicobacter|November 27, 2022
Discussion on the common controversies of Helicobacter pylori infectionHang Yang, Yi Mou, Bing Hu
Helicobacter|December 2, 2022
Quadruple therapy with vonoprazan 20 mg daily as a first-line treatment for Helicobacter pylori infection: A single-center, open-label, noninferiority, randomized controlled trialLifen Lu, Yujing Wang, Jun Ye, et al.
Helicobacter|December 5, 2022
Helicobacter pylori regulated microRNA map of human gastric cellsPoornima Ramesh, Sreeranjini Babu, Shruthi Ammankallu, et al.
Helicobacter|December 8, 2022
Helicobacter pylori, gastrointestinal microbiota, and immunotherapyZhongxue Han, Yueyue Li, Yanqing Li
Helicobacter|June 9, 2022
Influences of Helicobacter pylori infection on diversity, heterogeneity, and composition of human gastric microbiomes across stages of gastric cancer developmentWanmeng Xiao, Zhanshan Sam Ma
Helicobacter|December 28, 2019
Mucoid and coccoid Helicobacter pylori with fast growth and antibiotic resistanceSara Kadkhodaei, Farideh Siavoshi, Kambiz Akbari Noghabi
Helicobacter|October 1, 2020
The relation between Helicobacter pylori immunoglobulin G seropositivity and leukocyte telomere length in US adults from NHANES 1999-2000Jin-Wen Huang, Chuanbo Xie, Zhongzheng Niu, et al.
Helicobacter|October 28, 2020
Modified bismuth quadruple therapy with low-dose metronidazole as first-line therapy for Helicobacter pylori infectionGyu Young Pih, Kee Don Choi, Eun Jeong Gong, et al.
Pageof 230

Showing results (421-430 of 2,296) with videos related to

Sort By:
Pageof 230
Helicobacter|June 1, 2022
Efficacy and safety of low-dose rifabutin-based 7-day triple therapy as a third- or later-line Helicobacter pylori eradication regimenKazumi Inokuchi, Hideki Mori, Juntaro Matsuzaki, et al.
Helicobacter|December 20, 2022
Helicobacter pylori-positive chronic atrophic gastritis and cellular senescenceShi-Yu Zheng, Lu Zhu, Lu-Yi Wu, et al.
Helicobacter|November 27, 2022
Discussion on the common controversies of Helicobacter pylori infectionHang Yang, Yi Mou, Bing Hu
Helicobacter|December 2, 2022
Quadruple therapy with vonoprazan 20 mg daily as a first-line treatment for Helicobacter pylori infection: A single-center, open-label, noninferiority, randomized controlled trialLifen Lu, Yujing Wang, Jun Ye, et al.
Helicobacter|December 5, 2022
Helicobacter pylori regulated microRNA map of human gastric cellsPoornima Ramesh, Sreeranjini Babu, Shruthi Ammankallu, et al.
Helicobacter|December 8, 2022
Helicobacter pylori, gastrointestinal microbiota, and immunotherapyZhongxue Han, Yueyue Li, Yanqing Li
Helicobacter|June 9, 2022
Influences of Helicobacter pylori infection on diversity, heterogeneity, and composition of human gastric microbiomes across stages of gastric cancer developmentWanmeng Xiao, Zhanshan Sam Ma
Helicobacter|December 28, 2019
Mucoid and coccoid Helicobacter pylori with fast growth and antibiotic resistanceSara Kadkhodaei, Farideh Siavoshi, Kambiz Akbari Noghabi
Helicobacter|October 1, 2020
The relation between Helicobacter pylori immunoglobulin G seropositivity and leukocyte telomere length in US adults from NHANES 1999-2000Jin-Wen Huang, Chuanbo Xie, Zhongzheng Niu, et al.
Helicobacter|October 28, 2020
Modified bismuth quadruple therapy with low-dose metronidazole as first-line therapy for Helicobacter pylori infectionGyu Young Pih, Kee Don Choi, Eun Jeong Gong, et al.
Pageof 230